CRISPR and Genome Editing – Products

BioSpring GmbH and Pantherna Therapeutics GmbH, have agreed on a strategic collaboration in the field of research and development and signed a cooperation agreement mid-July.

Freudenberg Medical, has expanded its biopharma product portfolio to include custom single-use assemblies which combine Freudenberg’s expertise in silicone extrusion and molding.

Strategic activation unites best-in-class technology with end-to-end development solutions to optimize therapeutic development process.

The teams aim to redefine plasmid sequencing with nanopore technology and global accessibility.

To support today’s modern laboratories, Thermo Fisher Scientific is introducing several new columns to meet researchers’ analytical, efficiency, and scalability needs at HPLC 2024, taking place in Denver, CO from July 20 – 25.

AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research.

AMSBIO offers a wide range of products to support skeletal muscle cell culture enabling you to streamline your modelling process in vitro.

Companies form expert working group to introduce essential tools for AAV development and research professionals.

Novel multiplexing technology enables seamless sample pooling facilitating cost-efficient single cell experiments for compound screening and translational research.

circVec 2.1 DNA vectors have now demonstrated higher and more durable expression vs. conventional mRNA-based expression in vivo for up to five months.